Globus Medical, Inc. Class A Common Stock (GMED)
R&D Expenses
$184.82M
TTM · Period ending: · USD
GMED R&D Expenses
Latest reported$184.82Mperiod ending
Latest reported$184.82Mperiod ending
GMED TTM R&D Expenses ($23.46M → $184.82M)
TTM R&D Expenses
High-resolution chart · PNG
GMED r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 184,815,000 | |
| 188,448,000 | |
| 185,000,000 | |
| 144,491,000 | |
| 141,804,000 | |
| 139,548,000 | |
| 163,754,000 | |
| 182,598,000 | |
| 176,547,000 | |
| 160,196,000 | |
| 124,010,000 | |
| 91,265,000 | |
| 80,637,000 | |
| 76,685,000 | |
| 73,015,000 | |
| 104,530,000 | |
| 101,682,000 | |
| 99,834,000 | |
| 97,346,000 | |
| 61,565,000 | |
| 60,133,000 | |
| 84,041,000 | |
| 84,519,000 | |
| 84,774,000 | |
| 84,861,000 | |
| 61,152,000 | |
| 60,074,000 | |
| 58,336,000 | |
| 59,355,000 | |
| 57,132,000 | |
| 55,497,000 | |
| 53,152,000 | |
| 48,512,000 | |
| 45,702,000 | |
| 43,679,000 | |
| 45,909,000 | |
| 45,287,000 | |
| 45,168,000 | |
| 44,532,000 | |
| 40,725,000 | |
| 39,710,000 | |
| 38,197,000 | |
| 36,823,000 | |
| 35,391,000 | |
| 34,287,000 | |
| 32,900,000 | |
| 31,687,000 | |
| 29,701,000 | |
| 28,123,000 | |
| 27,466,000 | |
| 26,870,000 | |
| 27,680,000 | |
| 28,134,000 | |
| 28,037,000 | |
| 27,926,000 | |
| 26,471,000 | |
| 25,365,000 | |
| 24,160,000 | |
| 23,464,000 |